Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors

F. Cosci*, S. Romanazzo, G. Mansueto, P. Rontani, M.N. Levitan, R.D. Halkjoer-Lassen, L.A. Quagliato, T. Nakamura, K. Uematsu, A.E. Nardi, M. Oe, V.A. Chouinard, G. Chouinard

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Clinical Utility of Semistructured Interview and Scales to Assess Withdrawal Syndromes With Dose Reduction or Discontinuation of Selective Serotonin Reuptake Inhibitors or Serotonin Norepinephrine Reuptake Inhibitors'. Together they form a unique fingerprint.

Keyphrases

INIS

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science